Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects
- PMID: 3497054
- DOI: 10.1007/BF00239745
Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects
Abstract
Sera from 51 HTLV-III (human immunodeficiency virus, HIV)-antibody positive subjects consisting of 21 asymptomatic individuals and 15 ARC and 15 AIDS patients were analyzed for their serological profiles toward the viral antigens. One of the asymptomatic subjects only showed a p24 reactivity in the immunoblot, but antibodies to the env antigens were clearly identified by immunoprecipitation of viral antigens (RIP) followed by SDS-polyacrylamide gel electrophoresis. RIP patterns of different subjects and even different bleeds from the same subjects showed a varying reactivity to the gag antigens whereas the reactivity towards the env antigens appeared to be generally stable. RIP analysis of sequential sera of virus-infected individuals indicated a pattern consistent with an initial steady rise of antibody reactivities to the gag antigens relative to the reactivities to the envelope antigens. These reactivities reached a plateau and then slowly declined. While all sera tested had antibodies to the envelope antigens gp160, gp120 and gp41, 86% of the asymptomatic subjects, 67% of the ARC patients and only 33% of the AIDS patients had antibodies to the gag proteins p24 and pr53gag.
Similar articles
-
Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status.Blood. 1987 Feb;69(2):437-41. Blood. 1987. PMID: 3467797
-
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs.J Infect Dis. 1988 Apr;157(4):805-11. doi: 10.1093/infdis/157.4.805. J Infect Dis. 1988. PMID: 3346572
-
[Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].Hautarzt. 1988 Jan;39(1):45-8. Hautarzt. 1988. PMID: 3162727 German.
-
Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.Cancer Res. 1985 Sep;45(9 Suppl):4534s-4538s. Cancer Res. 1985. PMID: 2990682 Review.
-
Proposed immunopathogenic factors associated with progression from human immunodeficiency virus seropositivity to clinical disease.J Clin Microbiol. 1987 Oct;25(10):1817-21. doi: 10.1128/jcm.25.10.1817-1821.1987. J Clin Microbiol. 1987. PMID: 3312284 Free PMC article. Review. No abstract available.
Cited by
-
Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.J Clin Microbiol. 1989 May;27(5):843-8. doi: 10.1128/jcm.27.5.843-848.1989. J Clin Microbiol. 1989. PMID: 2501350 Free PMC article.
-
Challenges of antibody-mediated protection against HIV-1.Expert Rev Vaccines. 2010 Jul;9(7):683-7. doi: 10.1586/erv.10.70. Expert Rev Vaccines. 2010. PMID: 20624038 Free PMC article. No abstract available.
-
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.PLoS Med. 2007 Dec;4(12):e343. doi: 10.1371/journal.pmed.0040343. PLoS Med. 2007. PMID: 18052604 Free PMC article.
-
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.BMC Infect Dis. 2011 Sep 26;11:254. doi: 10.1186/1471-2334-11-254. BMC Infect Dis. 2011. PMID: 21943091 Free PMC article.
-
Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.J Clin Microbiol. 1994 Jun;32(6):1449-56. doi: 10.1128/jcm.32.6.1449-1456.1994. J Clin Microbiol. 1994. PMID: 8077388 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous